Literature DB >> 19885730

Expression and subcellular location of alpha-synuclein during mouse-embryonic development.

Shan-chuan Zhong1, Xue Luo, Xing-shu Chen, Qi-yan Cai, Jing Liu, Xing-hua Chen, Zhong-xiang Yao.   

Abstract

Alpha-synuclein (alpha-SYN) is one of the major components of intracellular fibrillary aggregates in the brains of a subset of neurodegenerative disorders. Although alpha-SYN expression has been found in developing mouse brain, a detailed distribution during mouse-embryonic development has not been made. Here we describe the expression pattern of alpha-SYN during the development of mice from E9.5 to P0 by immunohistochemistry (IHC). As a result, alpha-SYN was detected as early as E9.5. During the embryonic stages, alpha-SYN was dynamically expressed in several regions of the brain. In the neocortex, expression was detected in the marginal zone (MZ) in the early stages and was later condensed in the MZ and in the subplate (SP); in the cerebellum, expression was initially detected in the deep cerebellar nuclei (DCN) and was later condensed in the Purkinje cells. These spatio-temporal expression patterns matched the neuronal migratory pathways and the formation of the synapse connections. Additionally, alpha-SYN was detected in the sensory systems, including the nasal mucosa, the optic cup, the sensory ganglia, and their dominating nerve fibers. Furthermore, the nuclear location of alpha-SYN protein was found in developing neurons in the early stages, and later it was mostly found in the non-nuclear compartments. This finding was further confirmed by Western blot analysis. These results suggest that alpha-SYN may be involved not only in the migration of neurons and in the synaptogenesis of the central nervous system (CNS) but also in the establishment of the sensory systems. The nuclear location of alpha-SYN may hint at an important function in these events.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19885730     DOI: 10.1007/s10571-009-9473-4

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  54 in total

1.  Nuclear localization of alpha-synuclein and its interaction with histones.

Authors:  John Goers; Amy B Manning-Bog; Alison L McCormack; Ian S Millett; Sebastian Doniach; Donato A Di Monte; Vladimir N Uversky; Anthony L Fink
Journal:  Biochemistry       Date:  2003-07-22       Impact factor: 3.162

2.  Extensive nuclear localization of alpha-synuclein in normal rat brain neurons revealed by a novel monoclonal antibody.

Authors:  S Yu; X Li; G Liu; J Han; C Zhang; Y Li; S Xu; C Liu; Y Gao; H Yang; K Uéda; P Chan
Journal:  Neuroscience       Date:  2007-02-01       Impact factor: 3.590

3.  Characterization of a novel protein regulated during the critical period for song learning in the zebra finch.

Authors:  J M George; H Jin; W S Woods; D F Clayton
Journal:  Neuron       Date:  1995-08       Impact factor: 17.173

4.  Sensory perception in Parkinson disease.

Authors:  E E Jobst; M E Melnick; N N Byl; G A Dowling; M J Aminoff
Journal:  Arch Neurol       Date:  1997-04

5.  Membrane association and protein conformation of alpha-synuclein in intact neurons. Effect of Parkinson's disease-linked mutations.

Authors:  P J McLean; H Kawamata; S Ribich; B T Hyman
Journal:  J Biol Chem       Date:  2000-03-24       Impact factor: 5.157

6.  Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells.

Authors:  Xiangmin Peng; Xiangmin M Peng; Roya Tehranian; Paula Dietrich; Leonidas Stefanis; Ruth G Perez
Journal:  J Cell Sci       Date:  2005-07-19       Impact factor: 5.285

7.  Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies.

Authors:  S S Lee; Y M Kim; E Junn; G Lee; K-H Park; M Tanaka; R D Ronchetti; M M Quezado; M M Mouradian
Journal:  Neurobiol Aging       Date:  2003-09       Impact factor: 4.673

8.  Patterns of FOS expression in the spinal cord and periaqueductal grey matter of 6OHDA-lesioned rats.

Authors:  Stephanie Reyes; John Mitrofanis
Journal:  Int J Neurosci       Date:  2008-08       Impact factor: 2.292

Review 9.  Visual dysfunction, neurodegenerative diseases, and aging.

Authors:  Gregory R Jackson; Cynthia Owsley
Journal:  Neurol Clin       Date:  2003-08       Impact factor: 3.806

10.  Structural determinants of PLD2 inhibition by alpha-synuclein.

Authors:  Jacqueline E Payton; Richard J Perrin; Wendy S Woods; Julia M George
Journal:  J Mol Biol       Date:  2004-04-02       Impact factor: 5.469

View more
  20 in total

1.  Determining nuclear localization of alpha-synuclein in mouse brains.

Authors:  Z Huang; Z Xu; Y Wu; Y Zhou
Journal:  Neuroscience       Date:  2011-10-19       Impact factor: 3.590

2.  Conditional expression of Parkinson's disease-related mutant α-synuclein in the midbrain dopaminergic neurons causes progressive neurodegeneration and degradation of transcription factor nuclear receptor related 1.

Authors:  Xian Lin; Loukia Parisiadou; Carmelo Sgobio; Guoxiang Liu; Jia Yu; Lixin Sun; Hoon Shim; Xing-Long Gu; Jing Luo; Cai-Xia Long; Jinhui Ding; Yolanda Mateo; Patricia H Sullivan; Ling-Gang Wu; David S Goldstein; David Lovinger; Huaibin Cai
Journal:  J Neurosci       Date:  2012-07-04       Impact factor: 6.167

3.  Comparison of newly generated doublecortin-immunoreactive neuronal progenitors in the main olfactory bulb among variously aged gerbils.

Authors:  Jung Hoon Choi; Ki-Yeon Yoo; Choong Hyun Lee; Ok Kyu Park; Bing Chun Yan; Hua Li; In Koo Hwang; Jeong Ho Park; Sung Koo Kim; Moo-Ho Won
Journal:  Neurochem Res       Date:  2010-07-06       Impact factor: 3.996

4.  Formation of neurodegenerative aggresome and death-inducing signaling complex in maternal diabetes-induced neural tube defects.

Authors:  Zhiyong Zhao; Lixue Cao; E Albert Reece
Journal:  Proc Natl Acad Sci U S A       Date:  2017-04-10       Impact factor: 11.205

5.  Synaptic Regulator α-Synuclein in Dopaminergic Fibers Is Essentially Required for the Maintenance of Subependymal Neural Stem Cells.

Authors:  Ana Perez-Villalba; M Salomé Sirerol-Piquer; Germán Belenguer; Raúl Soriano-Cantón; Ana Belén Muñoz-Manchado; Javier Villadiego; Diana Alarcón-Arís; Federico N Soria; Benjamin Dehay; Erwan Bezard; Miquel Vila; Analía Bortolozzi; Juan José Toledo-Aral; Francisco Pérez-Sánchez; Isabel Fariñas
Journal:  J Neurosci       Date:  2017-12-07       Impact factor: 6.167

Review 6.  The synaptic pathology of alpha-synuclein aggregation in dementia with Lewy bodies, Parkinson's disease and Parkinson's disease dementia.

Authors:  Walter J Schulz-Schaeffer
Journal:  Acta Neuropathol       Date:  2010-06-20       Impact factor: 17.088

7.  The novel Parkinson's disease linked mutation G51D attenuates in vitro aggregation and membrane binding of α-synuclein, and enhances its secretion and nuclear localization in cells.

Authors:  Mohamed-Bilal Fares; Nadine Ait-Bouziad; Igor Dikiy; Martial K Mbefo; Ana Jovičić; Aoife Kiely; Janice L Holton; Seung-Jae Lee; Aaron D Gitler; David Eliezer; Hilal A Lashuel
Journal:  Hum Mol Genet       Date:  2014-04-11       Impact factor: 6.150

Review 8.  Genetic and Environmental Factors in Parkinson's Disease Converge on Immune Function and Inflammation.

Authors:  Elizabeth M Kline; Madelyn C Houser; Mary K Herrick; Philip Seibler; Christine Klein; Andrew West; Malú G Tansey
Journal:  Mov Disord       Date:  2020-12-14       Impact factor: 10.338

9.  Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus.

Authors:  Michael J Devine; Mina Ryten; Petr Vodicka; Alison J Thomson; Tom Burdon; Henry Houlden; Fatima Cavaleri; Masumi Nagano; Nicola J Drummond; Jan-Willem Taanman; Anthony H Schapira; Katrina Gwinn; John Hardy; Patrick A Lewis; Tilo Kunath
Journal:  Nat Commun       Date:  2011-08-23       Impact factor: 14.919

10.  Endogenous alpha-synuclein influences the number of dopaminergic neurons in mouse substantia nigra.

Authors:  Pablo Garcia-Reitboeck; Oleg Anichtchik; Jeffrey W Dalley; Natalia Ninkina; George K Tofaris; Vladimir L Buchman; Maria Grazia Spillantini
Journal:  Exp Neurol       Date:  2013-08-08       Impact factor: 5.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.